Pelagos Insurance buyback authorization reaches $400M
Common shareholders of record on December 11, 2026, are scheduled to receive a $0.22 quarterly dividend on December 23.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
6-K
Rhea-AI Filing Summary
Pelagos Insurance Capital Ltd replenished its common share repurchase authorization, bringing the total current authorization to $400.0 million, and its board approved an increase in the quarterly common share dividend to $0.22 per share. The dividend is payable on December 23, 2026, to common shareholders of record on December 11, 2026.
The company says it will determine the timing, number and value of any repurchases at its discretion, and the board may suspend or discontinue the program at any time. Group Chief Executive Officer Dan Burrows said the company remained on track to deliver mid-single-digit top-line growth in 2026.
1 point · 0 major0 major · 0 points
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Positive
- Moderate pointQuarterly common share dividend increased to $0.22 per share.
Negative
- None.
Key Figures
Total current share repurchase authorization: $400.0 million
Quarterly common share dividend: $0.22 per share
Dividend record date: December 11, 2026
+2 more
5 metrics
Total current share repurchase authorization
$400.0 million
After replenishment
Quarterly common share dividend
$0.22 per share
Increased dividend declared by the board
Dividend record date
December 11, 2026
Common shareholders of record
Dividend payment date
December 23, 2026
Declared quarterly dividend
Top-line growth outlook
Mid-single-digit growth
2026 outlook stated by Group Chief Executive Officer Dan Burrows
Key Terms
Rule 10b-18, accelerated share repurchases, Rule 10b5-1
3 terms
Rule 10b-18 regulatory
"open market purchases under Rule 10b-18"
Rule 10b-18 is a regulation that sets strict rules for how a company's executives and employees can buy back their own company's stock from the market. It helps ensure that these buybacks happen in a fair and transparent way, reducing the chance of market manipulation. This is important for investors because it offers protection against unfair practices and promotes confidence in the integrity of the stock market.
Rule 10b5-1 regulatory
"a trading plan meeting the requirements of Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What is PLGO's quarterly dividend?
Pelagos Insurance Capital approved and declared a quarterly common share dividend of $0.22 per share, payable on December 23, 2026, to common shareholders of record on December 11, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
November 3, 2026
Commission File Number: 001-41731
PELAGOS INSURANCE CAPITAL LIMITED
(Exact Name of Registrant as Specified in its Charter)
(Exact Name of Registrant as Specified in its Charter)
Wellesley House South, 90 Pitts Bay Road, Pembroke, Bermuda, HM08
+1 441 279 2590
(Address of Principal Executive Office)
+1 441 279 2590
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
On November 3, 2026, Pelagos Insurance Capital Limited (formerly known as Fidelis Insurance Holdings Limited) (the “Company”) issued a press release announcing that its board of directors has (i) approved the replenishment of the Company’s common share repurchase authorization, bringing the total current authorization to $400.0 million, and (ii) approved an increase in the quarterly common share dividend to $0.22 per share. The Board declared the dividend payable on December 23, 2026, to common shareholders of record on December 11, 2026.
A copy of the press release is attached hereto as Exhibit 99.1.
EXHIBIT INDEX
Exhibit
99.1 | Press Release dated November 3, 2026 | ||||
Pursuant to the requirement of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
PELAGOS INSURANCE CAPITAL LIMITED | |||||||||||
Dated: November 3, 2026 | By: | /s/ Allan C. Decleir | |||||||||
Name: | Allan C. Decleir | ||||||||||
Title: | Group Chief Financial Officer | ||||||||||
Pelagos Insurance Capital Expands Capital Management Initiatives
Replenishes common share repurchase authorization to $400.0 million
Increases quarterly common share dividend to $0.22 per share
PEMBROKE, Bermuda, November 3, 2026 — Pelagos Insurance Capital Limited (NYSE:PLGO) (“Pelagos Insurance Capital” or the “Company”), an expert capital allocator and risk selector in specialty insurance and reinsurance, announced today an expansion of its capital management initiatives. The Company's Board of Directors has approved the replenishment of its common share repurchase authorization, bringing the total current authorization to $400.0 million, and an increase in the quarterly common share dividend to $0.22 per share. The Board declared the dividend payable on December 23, 2026, to common shareholders of record on December 11, 2026.
Dan Burrows, Group Chief Executive Officer of Pelagos Insurance Capital, commented, “As a strategic capital allocator, we are continually assessing how best to deploy our capital to create long-term shareholder value across accretive underwriting, outwards reinsurance, and returns to shareholders. Today’s actions reflect the strength of our balance sheet and our ability to increase capital returns while continuing to pursue profitable growth opportunities. We remain on track to deliver mid-single-digit top line growth in 2026, supported by our expanding network of underwriting partners, as we continue to return value to shareholders through dividends and accretive share repurchases.”
Additional details: Share Repurchase Authorization and Dividend
Share Repurchase Authorization: The Company's Board of Directors has approved the replenishment of its common share repurchase program (the “Program”), bringing the total current authorization to $400.0 million. Pursuant to the Program, the Company may repurchase common shares through a combination of open market purchases under Rule 10b-18 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), accelerated share repurchases or privately negotiated transactions, as well as pursuant to a trading plan meeting the requirements of Rule 10b5-1 under the Exchange Act.
The timing as well as the number and value of common shares repurchased under the Program will be determined by the Company at its discretion and will depend on a variety of factors, including its assessment of the intrinsic value of the Company’s common shares, attractive growth opportunities, the market price of the Company’s common shares, general market and economic conditions, available liquidity, compliance with the Company’s debt and other agreements, applicable legal, regulatory and contractual restrictions and the Company’s capital and business strategy. The Program may be suspended or discontinued by the Board of Directors at any time.
Dividend: The Company's Board of Directors has approved and declared a dividend of $0.22 per share, payable on December 23, 2026, to common shareholders of record on December 11, 2026.
About Pelagos Insurance Capital
Pelagos Insurance Capital (NYSE: PLGO), formerly Fidelis Insurance Group (NYSE: FIHL), is an expert capital allocator and risk selector in specialty insurance and reinsurance. We bring together strategic capital and specialist underwriting expertise to deliver value through the cycle.
With a differentiated, diversified portfolio and strong balance sheet, we deploy capital into the most compelling areas of the market through our network of best-in-class underwriting partners. Our deep expertise and multiple points of access to the market enable us to adapt as the market evolves, optimize performance, and produce superior outcomes for clients, brokers, and shareholders.
Pelagos Insurance Capital makes the connections that matter in specialty risk.
For additional information about Pelagos Insurance Capital, our people, products and our insurer financial strength ratings please visit our website at www.pelagosinsurancecapital.com.
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
Certain statements contained in this press release constitute “forward-looking statements,” and are made pursuant to the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation, statements regarding the Company’s timing and ability to pay dividends, the Company’s plans to return capital to shareholders, and the Company's business strategy and plans. These statements reflect management’s current beliefs, expectations, assumptions, estimates and projections. While management believes these expectations, assumptions, estimates and projections are reasonable, such forward-looking statements are neither promises nor guarantees and are subject to known and unknown risks and uncertainties, many of which are beyond management’s control. These statements involve risks and uncertainties that may cause the Company’s actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Important risk factors regarding the Company can be found under the heading “Risk Factors” in the Company’s Annual Report on Form 20-F for the year ended December 31, 2025, which are incorporated herein by reference, as such factors may be updated from time to time in the Company's subsequent current reports and other filings with the SEC available electronically at www.sec.gov. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to rely on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements after the date of this press release, whether as a result of new information, future events, or otherwise.
Pelagos Insurance Capital Investor Contact:
Pelagos Insurance Capital
Miranda Hunter
+1 (441) 279 2561
+1 (441) 279 2561
Pelagos Insurance Capital Media Contact:
Rein4ce
Stephen Breen
+44 (0) 7843 076556